HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure

Arnold Piek, Wouter C. Meijers, Nicolas F. Schroten, Ron T. Gansevoort, Rudolf A. de Boer, Herman H. W. Sillje*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

53 Citations (Scopus)
292 Downloads (Pure)

Abstract

Background: The novel biomarker human epididymis protein 4 (HE4) shows prognostic value in acute heart failure (HF) patients. We measured HE4 levels in patients with chronic heart failure (CHF) and correlated them to HF severity, kidney function, and HF biomarkers, and determined its predictive value.

Methods: Serum HE4 levels in patients (n = 101) with stable CHF with reduced left ventricular ejection fraction (LVEF

Results: HE4 levels were higher in CHF compared with control subjects (69.2 pmol/L [interquartile range 55.6-93.8] vs 56.1 pmol/L [46.6-69.0]; P

Conclusions: HE4 levels are increased in CHF, correlate with HF severity and kidney function, and predict HF outcome.

Original languageEnglish
Pages (from-to)12-19
Number of pages8
JournalJournal of Cardiac Failure
Volume23
Issue number1
DOIs
Publication statusPublished - Jan-2017

Keywords

  • HE4
  • WFDC2
  • chronic heart failure
  • fibrosis
  • EPIDIDYMIS PROTEIN 4
  • TASK-FORCE
  • GUIDELINES
  • PROGNOSIS
  • DIAGNOSIS
  • BIOMARKER

Fingerprint

Dive into the research topics of 'HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure'. Together they form a unique fingerprint.

Cite this